{
    "Trade/Device Name(s)": [
        "Aperio AT2 DX System"
    ],
    "Submitter Information": "Leica Biosystems Imaging, Inc.",
    "510(k) Number": "K190332",
    "Predicate Device Reference 510(k) Number(s)": [
        "DEN160056"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PSY"
    ],
    "Summary Letter Date": "February 13, 2019",
    "Summary Letter Received Date": "February 14, 2019",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.3700"
    ],
    "Regulation Name(s)": [
        "Whole slide imaging system"
    ],
    "Analyte Class(es)": [
        "anatomic pathology"
    ],
    "Analyte(s)": [],
    "Specimen Type(s)": [
        "Formalin-fixed paraffin embedded (FFPE) tissue"
    ],
    "Specimen Container(s)": [
        "Glass slide"
    ],
    "Instrument(s)/Platform(s)": [
        "Aperio AT2 DX scanner",
        "ImageScope DX review application",
        "Display"
    ],
    "Method(s)/Technology(ies)": [
        "Digital slide scanning",
        "Digital image review"
    ],
    "Methodologies": [
        "Whole slide imaging"
    ],
    "Submission Type(s)": [
        "System",
        "Scanner",
        "Software",
        "Display"
    ],
    "Document Summary": "FDA 510(k) summary for Aperio AT2 DX System, a digital slide creation and viewing system for primary diagnosis in surgical pathology using FFPE tissue slides.",
    "Indications for Use Summary": "Intended for in vitro diagnostic use as an aid to the pathologist to review and interpret digital images of surgical pathology slides prepared from formalin-fixed paraffin embedded (FFPE) tissue; not intended for use with frozen section, cytology, or non-FFPE hematopathology specimens.",
    "fda_folder": "Pathology"
}